Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoronaVac efficacy and safety in children and adolescents
NCT04992260Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Sep 2021
- Primary completion
- May 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 4
01
Overview
A Phase 3 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Biotech Ltd.. Started Sep 2021; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04992260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04992260.